Lu Yunxia, Cross Amanda J, Murphy Neil, Freisling Heinz, Travis Ruth C, Ferrari Pietro, Katzke Verena A, Kaaks Rudolf, Olsson Åsa, Johansson Ingegerd, Renström Frida, Panico Salvatore, Pala Valeria, Palli Domenico, Tumino Rosario, Peeters Petra H, Siersema Peter D, Bueno-de-Mesquita H B, Trichopoulou Antonia, Klinaki Eleni, Tsironis Christos, Agudo Antonio, Navarro Carmen, Sánchez María-José, Barricarte Aurelio, Boutron-Ruault Marie-Christine, Fagherazzi Guy, Racine Antoine, Weiderpass Elisabete, Gunter Marc J, Riboli Elio
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, W2 1PG, UK.
International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Cancer Causes Control. 2016 Jul;27(7):919-27. doi: 10.1007/s10552-016-0772-z. Epub 2016 Jun 13.
The etiology of small intestinal cancer (SIC) is largely unknown, and there are very few epidemiological studies published to date. No studies have investigated abdominal adiposity in relation to SIC.
We investigated overall obesity and abdominal adiposity in relation to SIC in the European Prospective Investigation into Cancer and Nutrition (EPIC), a large prospective cohort of approximately half a million men and women from ten European countries. Overall obesity and abdominal obesity were assessed by body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR). Multivariate Cox proportional hazards regression modeling was performed to estimate hazard ratios (HRs) and 95 % confidence intervals (CIs). Stratified analyses were conducted by sex, BMI, and smoking status.
During an average of 13.9 years of follow-up, 131 incident cases of SIC (including 41 adenocarcinomas, 44 malignant carcinoid tumors, 15 sarcomas and 10 lymphomas, and 21 unknown histology) were identified. WC was positively associated with SIC in a crude model that also included BMI (HR per 5-cm increase = 1.20, 95 % CI 1.04, 1.39), but this association attenuated in the multivariable model (HR 1.18, 95 % CI 0.98, 1.42). However, the association between WC and SIC was strengthened when the analysis was restricted to adenocarcinoma of the small intestine (multivariable HR adjusted for BMI = 1.56, 95 % CI 1.11, 2.17). There were no other significant associations.
WC, rather than BMI, may be positively associated with adenocarcinomas but not carcinoid tumors of the small intestine.
Abdominal obesity is a potential risk factor for adenocarcinoma in the small intestine.
小肠癌(SIC)的病因在很大程度上尚不清楚,迄今为止发表的流行病学研究非常少。尚无研究调查腹部肥胖与小肠癌的关系。
我们在欧洲癌症与营养前瞻性调查(EPIC)中调查了总体肥胖和腹部肥胖与小肠癌的关系,该研究是一项大型前瞻性队列研究,涉及来自十个欧洲国家的约五十万名男性和女性。通过体重指数(BMI)、腰围(WC)、臀围(HC)、腰臀比(WHR)和腰高比(WHtR)评估总体肥胖和腹部肥胖。进行多变量Cox比例风险回归建模以估计风险比(HR)和95%置信区间(CI)。按性别、BMI和吸烟状况进行分层分析。
在平均13.9年的随访期间,共确定了131例小肠癌新发病例(包括41例腺癌、44例恶性类癌肿瘤、15例肉瘤和10例淋巴瘤,以及21例组织学类型不明的病例)。在一个也包括BMI的粗模型中,WC与小肠癌呈正相关(每增加5厘米的HR = 1.20,95% CI 1.04,1.39),但在多变量模型中这种关联减弱(HR 1.18,95% CI 0.98,1.42)。然而,当分析仅限于小肠腺癌时,WC与小肠癌之间的关联增强(根据BMI调整的多变量HR = 1.56,95% CI 1.11,2.17)。没有其他显著关联。
WC而非BMI可能与小肠腺癌呈正相关,但与小肠类癌肿瘤无关。
腹部肥胖是小肠腺癌的一个潜在危险因素。